According to reports from Business Standard, Mercury Laboratories reported a 15.97% decline in standalone net profit to ₹1.00 crore in the quarter ended December 2025, compared to ₹1.19 crore in the corresponding quarter of the previous year. The company's sales revenue declined by 6.23% to ₹18.35 crore in Q3 FY2026, down from ₹19.57 crore recorded in Q3 FY2025. As per latest market data, the company's total income for the quarter ended December 2025 was ₹35.99 crore, representing a 4.24% growth from the previous quarter's ₹34.53 crore and a 26.01% increase from the same quarter last year's ₹28.56 crore.
As reported by Business Standard, the company's operating profit margin (OPM) decreased to 13.79% in the December 2025 quarter from 10.12% in the same period last year. The profit before depreciation and tax (PBDT) increased by 13% to ₹2.70 crore compared to ₹2.38 crore in the previous year. Profit before tax (PBT) also grew by 12% to ₹1.83 crore from ₹1.64 crore in Q3 FY2025. According to latest financial data, the company's net profit margin stands at 2.60% for the quarter ended December 2025, while the basic earnings per share (EPS) is ₹1.59.
According to the financial data reported by Business Standard, the company's sales revenue of ₹18.35 crore in Q3 FY2026 represents a 6.23% decline from ₹19.57 crore recorded in the corresponding quarter of the previous financial year. This revenue decline indicates challenging market conditions or operational adjustments during the quarter. As per latest market data, the company's total expenses for the quarter were ₹32.65 crore, showing a 1.13% decrease from the previous quarter's ₹33.02 crore, while EBIT increased significantly by 121.36% to ₹3.35 crore from the previous quarter's ₹1.51 crore.
According to latest market data, Mercury Laboratories shares are currently trading at ₹136.00 with a market capitalization of ₹79.92 crore. The stock has shown mixed performance with a 52-week high of ₹173.70 and a 52-week low of ₹109.00. The company's promoter holding stands at 61.27% as of December 2025, with no pledged shares and foreign institutional investors holding 0.0% of the stake. The company's total debt to equity ratio is 0.05, indicating a conservative financial position with total debt of ₹0.28 crore against equity of ₹104.34 crore.
